Researchers

Patient-Powered Biospecimens and Data

Procure Human Biospecimens Prospectively

Having confidence in your results requires access to clinically relevant biospecimen types and comprehensive datasets to make accurate conclusions. But sample criteria are increasingly specific, patient populations are harder and harder to reach, and study designs can seem impossible.

By leveraging an engaging direct-to-patient approach coupled with on-demand specimen procurement and data collection capabilities, you’ll touch even the hardest to reach populations. Our fully integrated service solution is simple and has you covered from start to finish—including same-day delivery.

1

1

Recruitment
& Screening

2

2

Informed Consent

3

3

@Home Sample
& Data Collection

4

4

Delivery

1

1

Recruitment
& Screening

2

2

Informed Consent

3

3

@Home Sample
& Data Collection

4

4

Delivery

Human Biospecimen Types

Our specimen procurement capabilities are minimally invasive and are further supported by in-home centrifugation, supplementary laboratory services (e.g., isolation of peripheral blood mononuclear cells (PBMCs), HLA typing, comprehensive clinical testing), and temperature-sensitive shipments according to your study protocol.

Blood-Derived Biofluids and Products

Non-Blood-Derived Biofluids

Integumentary Tissues

Why Sanguine

A custom-tailored approach means an enhanced ability to recruit participants and procure biospecimens prospectively. You’ll get more accurate data points per sample, increased study design flexibility, and an expedited time to completion.

1

Longitudinal and event-based biospecimen and data collection

2

Same-day specimen procurement and delivery

3

Nationwide patient member community to meet complex inclusion/exclusion criteria

4

Medical record-verified eligibility and pre-screening

5

Access to electronic medical records, health histories, patient-reported datasets

6

Long-term follow-up with study participants

We Specialize in These Conditions

Behind our therapeutic experience are patient member communities made up of more than 50,000 total members ready to advance science and medicine for the conditions they live with.

icons-70-x-70-genetic

Genetic

icons-70-x-70-neurodegenerative

Neurodegenerative & Neuropsychological

icons-70-x-70-hematological

Hematologic

icons-70-x-70-oncology

Oncology

icons-70-x-70-metabolic

Metabolic

icons-70-x-70-infectious-disease

Infectious Disease

icons-70-x-70-auto-immune-inflammatory

Autoimmune & Inflammatory

cardiovascular

Cardiovascular

icons-70-x-70-genetic

Genetic

icons-70-x-70-neurodegenerative

Neurodegenerative & Neuropsychological

icons-70-x-70-hematological

Hematologic

icons-70-x-70-oncology

Oncology

icons-70-x-70-metabolic

Metabolic

icons-70-x-70-infectious-disease

Infectious Disease

icons-70-x-70-auto-immune-inflammatory

Autoimmune & Inflammatory

cardiovascular

Cardiovascular

Get Samples for My Research

Compliance & Quality Assured

Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.

Sanguine utilizes two commercial, internationally-recognized IRBs for review and approval of all study protocols, specific study documentation, and study participant facing information. 

Advarra is organized and operates in compliance with the US and international regulations and policies governing research with human subjects, as applicable. These include but are not limited to: US federal regulations at 21 CFR parts 50, 56, 312, and 812; US federal regulations at 45 CFR part 46; Part C, Division 5 of the Canadian Food and Drug Regulations; the Canadian Tri-Council Policy Statement 2; and the International Conference on Harmonisation (ICH) E6, Good Clinical Practice (GCP). Advarra may rely upon federal or international guidance to inform its policy development and approaches. Advarra’s IRB is registered with FDA and OHRP. Advarra’s Federalwide Assurance (FWA) has been approved by OHRP; IRB Organization (IORG) Number is 0000635, FWA Number is 00023875 and IRB Registration Number is 00000971. Please note that the IRB registration number applies for both FDA and OHRP registrations and covers all general, therapeutically focused, and country-specific panels. Advarra is fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

WCG IRB is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process; all in compliance with requirements of FDA regulations 21 CFR Parts 50 and 56, HHS regulations 45 CFR 46, and International Conference on Harmonization (ICH) E6, Good Clinical Practice (GCP), as applicable. WCG IRB is registered with OHRP/FDA; IRB registration number is IRB00000533, parent organization number is IORG0000432 (WCG IRB Canada registration number is IRB00002354). WCG IRB also reviews in compliance with other applicable federal and state laws and regulations governing IRBs and research with human beings. Where appropriate, WCG IRB complies with additional regulations and guidelines (such as the Canadian Tri-Council Policy Statement, Ethical Conduct for Research Involving Humans) as required in specific research jurisdictions. WCG IRB continues to be fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).

Other Services

Longitudinal & Event-Based Collection

Patient Surveys & Questionnaires

Onsite & Same-Day Healthy Control Programs